Jeffrey Tan

Compliance with follow-up Test of Cure and outcomes after treatment for high-grade cervical intraepithelial neoplasia in Victoria, Australia

Jeffrey HJ Tan, Michael J Malloy, Julia ML Brotherton, Marion Saville

Journal article  |  2020  |  Australian and New Zealand Journal of Obstetrics and Gynaecology

Management and long-term outcomes of women with adenocarcinoma in situ of the cervix: A retrospective study

Jeffrey HJ Tan, Michael J Malloy, Ramaish Thangamani, Dorota Gertig, Kelly T Drennan, C David Wrede, Marion Saville, Michael Quinn

Journal article  |  2019  |  Australian and New Zealand Journal of Obstetrics and Gynaecology

How will transitioning from cytology to HPV testing change the balance between the benefits and harms of cervical cancer screening? Estimates of the impact on cervical cancer, treatment rates and adverse obstetric outcomes in Australia, a high vaccination coverage country

Louiza S Velentzis, Michael Caruana, Kate T Simms, Jie-Bin Lew, Ju-Fang Shi, Marion Saville, Megan A Smith, Sarah J Lord, Jeffrey Tan, Deborah Bateson, Michael Quinn, Karen Canfell

Journal article  |  2017  |  International Journal of Cancer

HPV genotype-specific concordance between EuroArray HPV, Anyplex II HPV28 and Linear Array HPV Genotyping test in Australian cervical samples

Alyssa M Cornall, Marin Poljak, Suzanne M Garland, Samuel Phillips, Dorothy A Machalek, Jeffrey H Tan, Michael A Quinn, Sepehr N Tabrizi

Journal article  |  2017  |  Papillomavirus Research

Cervical screening with primary HPV testing or cytology in a population of women in which those aged 33 years or younger had previously been offered HPV vaccination: Results of the Compass pilot randomised trial

Karen Canfell, Michael Caruana, Val Gebski, Jessica Darlington-Brown, Stella Heley, Julia Brotherton, Dorota Gertig, Chloe J Jennett, Annabelle Farnsworth, Jeffrey Tan, C David Wrede, Philip E Castle, Marion Saville

Journal article  |  2017  |  PLoS Medicine

Anyplex II HPV28 detection and Anyplex II HPV HR detection assays are highly concordant with other commercial assays for detection of high-risk HPV genotypes in women with high grade cervical abnormalities

AM Cornall, M Poljak, SM Garland, S Phillips, JH Tan, DA Machalek, MA Quinn, SN Tabrizi

Journal article  |  2017  |  European Journal of Clinical Microbiology & Infectious Diseases

Findings and Outcomes in a Prevaccination Cohort of Women Younger Than 25 Years Attending a Tertiary Colposcopy Service

Yasmin L Jayasinghe, Rani Bhat, Michael Quinn, C David H Wrede, Jeffrey HJ Tan

Journal article  |  2016  |  Journal of Lower Genital Tract Disease

Clinicians' attitude towards changes in Australian National Cervical Screening Program

Desiree Yap, Xinyu Liang, Suzanne M Garland, Stefanie Hartley, Alexandra Gorelik, Gina Ogilvie, Jeffrey Tan, C David H Wrede, Yasmin Jayasinghe

Journal article  |  2016  |  Journal of Clinical Virology

Evaluation of p16(INK4a) immunostaining for the detection of high-grade changes in cervical cytology

Sepehr N Tabrizi, Sarah E Tan, Christina von Knebel Doeberitz, Jeffery Tan, Michael A Quinn, Suzanne M Garland

Journal article  |  2015  |  Pathology

Comparison of the Roche Cobas (R) 4800 HPV assay to Digene Hybrid Capture 2, Roche Linear Array and Roche Amplicor for Detection of High-Risk Human Papillomavirus Genotypes in Women undergoing treatment for cervical dysplasia

Samuel Phillips, Suzanne M Garland, Jeffery H Tan, Michael A Quinn, Sepehr N Tabrizi

Journal article  |  2015  |  Journal of Clinical Virology